Correlation Between IShares Canadian and Arch Biopartners

Can any of the company-specific risk be diversified away by investing in both IShares Canadian and Arch Biopartners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Canadian and Arch Biopartners into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between iShares Canadian HYBrid and Arch Biopartners, you can compare the effects of market volatilities on IShares Canadian and Arch Biopartners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Canadian with a short position of Arch Biopartners. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Canadian and Arch Biopartners.

Diversification Opportunities for IShares Canadian and Arch Biopartners

-0.34

Correlation Coefficient

IShares Canadian  Arch Biopartners

Very good diversification

The 3 months correlation between IShares and Arch is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding iShares Canadian HYBrid and Arch Biopartners in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arch Biopartners and IShares Canadian is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Canadian HYBrid are associated (or correlated) with Arch Biopartners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arch Biopartners has no effect on the direction of IShares Canadian i.e., IShares Canadian and Arch Biopartners go up and down completely randomly.

Pair Corralation between IShares Canadian and Arch Biopartners

Assuming the 90 days trading horizon iShares Canadian HYBrid is expected to generate 0.07 times more return on investment than Arch Biopartners. However, iShares Canadian HYBrid is 13.42 times less risky than Arch Biopartners. It trades about -0.15 of its potential returns per unit of risk. Arch Biopartners is currently generating about -0.03 per unit of risk. If you would invest  1,990  in iShares Canadian HYBrid on October 10, 2024 and sell it today you would lose (12.00) from holding iShares Canadian HYBrid or give up 0.6% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

iShares Canadian HYBrid  vs.  Arch Biopartners

iShares Canadian HYBrid

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in iShares Canadian HYBrid are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy fundamental drivers, IShares Canadian is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Arch Biopartners

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Arch Biopartners are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable fundamental indicators, Arch Biopartners is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with IShares Canadian and Arch Biopartners

The main advantage of trading using opposite IShares Canadian and Arch Biopartners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Canadian position performs unexpectedly, Arch Biopartners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arch Biopartners will offset losses from the drop in Arch Biopartners' long position.

The idea behind iShares Canadian HYBrid and Arch Biopartners pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.